Start your Trading & Investing Journey with us
Join our channel for Daily Free Trades with Live analysis on Youtube, Trade Setup with Important Levels, and Important Stock Market Updates
Sudeep Pharma IPO Review - Issue Date, Price, GMP, Subscription, Allotment, Lot Size, and Details
Sudeep Pharma Limited IPO : Key Performance Indicators, PE Ratio, EPS, ROE, ROCE & RoNW
The Company Key Performance Indicates the pre-issue EPS of ₹12.78and post-issue EPS of ₹12.28 for FY25. The pre-issue P/E ratio is46.40x, while the post-issue P/E ratio is48.29x against the Industry P/E ratio is NA The company's ROE for FY25 is 28.13% and RoNW is 27.88%. The Annualised EPS is ₹11.07x and P/E is
53.55x. These metrics suggest that the IPO is Fully priced.
Key Performance Indicator
| KPI | Values |
|---|---|
| EPS Pre IPO (Rs.) | 12.78 |
| EPS Post IPO (Rs.) | 12.28 |
| Adjusted 12M EPS Post IPO (Rs.) | 11.07 |
| P/E Pre IPO | 46.40 |
| P/E Post IPO | 48.29 |
| Adjusted 12M P/E Post IPO | 53.55 |
| ROE | 28.13% |
| ROCE | 29.82% |
| P/BV | 12.93 |
| Debt/Equity | 0.2 |
| RoNW | 27.88% |
| EBITDA Margin | 39.70% |
| PAT Margin | 27.12% |
© 2022 CA Abhay Varn. All Rights Reserved Abhayvarn.com
